News

THAILAND: Advertising Specifications for Advertising License Exempted Medical Devices

THAILAND: Advertising Specifications for Advertising License Exempted Medical Devices

  • 2020-12-24 02:53:02

A person who wishes to advertise a medical device in Thailand must obtain a medical device advertising license upon any medical devices marketing activity. Thai FDA had published further advertising announcement regarding the advertising specifications of medical devices that are exempted to proceed advertising license registration to conveniently advertise medical devices.

More
TAIWAN: New  Draft on “Requirements for Indicating the Unique Device Identifier on Medical Device Labels"

TAIWAN: New Draft on “Requirements for Indicating the Unique Device Identifier on Medical Device Labels"

  • 2020-12-23 02:01:32

TFDA has recently announced a 3-stage schedule of implementing UDI system on labels of medical devices. Starting from June 1st, 2021, class 3 implantable medical devices are the first round of products that are required to comply with this regulation; followed by class 3 non-implantable medical devices starting from June 1st, 2022, and finally, class 2 medical devices starting from June 1st, 2023.

More
QT ACTIVITY: Qualtech Shares its Expertise on the Taiwanese Certification Procedures for MDs and Pharmaceuticals at the Taiwan Health Sector Conference in Germany  – November, 2020

QT ACTIVITY: Qualtech Shares its Expertise on the Taiwanese Certification Procedures for MDs and Pharmaceuticals at the Taiwan Health Sector Conference in Germany – November, 2020

  • 2020-11-26 10:42:10

The German-based “Society for Promotion of East West Knowledge Transfer” had invited the experts of Qualtech to share their knowledge on the Taiwan registration processes for medical devices and pharmaceutical products to a number of high-ranking and selected attendees. Within a 90-minute session held on November 10th, Qualtech guided participants through the different Taiwan certification procedures and further elaborated on the clinical requirements in place for pharmaceuticals.

More
TAIWAN: TFDA Announcement: Cease to comply with the regulation regarding "Products under classification I.0007 Hyaluronic Acid Implants required to conduct PSUR"  – November, 2020

TAIWAN: TFDA Announcement: Cease to comply with the regulation regarding "Products under classification I.0007 Hyaluronic Acid Implants required to conduct PSUR" – November, 2020

  • 2020-11-27 01:49:09

The previous regulation: “Products under classification I.0007 Hyaluronic Acid Implants required to conduct PSUR” is ceased since July 23rd, 2020. TFDA has re-evaluated the product safety and decided that each medical device under this classification may be reviewed individually for the necessity for conducting Periodic Safety Update Report (PSUR).

More